Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05609279 · ClinicalTrials.gov registry record
Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 60
- Enrollment target
NCT05609279 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 60 participants.
The verdict
NCT05609279 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study focuses on individuals with type 1 diabetes (T1D) and seeks to comprehensively study and understand several aspects of T1D including: susceptibility to hypoglycemia (low blood sugar) and improvement in hypoglycemia risk using of advanced diabetes technologies, such as continuous glucose monitoring (CGM); the differences among individuals with T1D in the risk of chronic complications, and minimize the psychosocial impact of T1D.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2024-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05609279
The ClinicalTrials.gov registry entry for NCT05609279 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05609279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05609279 about?
NCT05609279 is a clinical study titled "Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes". This study focuses on individuals with type 1 diabetes (T1D) and seeks to comprehensively study and understand several aspects of T1D including: susceptibility to hypoglycemia (low blood sugar) and improvement in hypoglycemia risk using of advanced diabetes technologies, such as continuous glucose m...
What is the current status of trial NCT05609279?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-02-18. Estimated completion is 2024-08-30.
Who is sponsoring clinical trial NCT05609279?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.